Stay updated on FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the normal study details with a simple error page.
    Difference
    18%
    Check dated 2026-09-21T22:30:31.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The page metadata was updated to revision v3.6.6, replacing the previous v3.6.5.
    Difference
    0.0%
    Check dated 2026-08-31T16:53:03.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    A funding attribution line '2019 ( U.S. NIH Grant/Contract )' was added, indicating NIH support for the study.
    Difference
    0.0%
    Check dated 2026-08-24T16:36:26.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    An updated site revision entry, v3.6.5, has been added, replacing the previous v3.6.4 in the revision history. This reflects a deployment or platform update rather than changes to the study data.
    Difference
    0.0%
    Check dated 2026-08-10T10:44:47.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page now displays an updated site revision to v3.6.4, signaling a software patch applied to the ClinicalTrials.gov interface. This update represents an interface-level change rather than a modification to the study data.
    Difference
    0.0%
    Check dated 2026-07-27T06:22:48.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.3, replacing v3.6.2, indicating a minor UI/version update to the page rendering. It does not modify the study data or how the page operates.
    Difference
    0.0%
    Check dated 2026-07-05T13:47:18.000Z thumbnail image

Stay in the know with updates to FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.